Federated Hermes’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,069
| Closed | -$1.71K | – | 2077 |
|
|
2025
Q1 | $1.71K | Buy |
+1,069
| New | +$1.71K | ﹤0.01% | 1961 |
|
|
2024
Q3 | – | Sell |
-316
| Closed | -$1.46K | – | 2070 |
|
|
2024
Q2 | $1.46K | Buy |
+316
| New | +$1.46K | ﹤0.01% | 1922 |
|
|
2023
Q4 | – | Sell |
-3,141
| Closed | -$5.84K | – | 2061 |
|
|
2023
Q3 | $5.84K | Buy |
3,141
+2,739
| +681% | +$5.09K | ﹤0.01% | 1872 |
|
|
2023
Q2 | $1.11K | Sell |
402
-3,055
| -88% | -$8.41K | ﹤0.01% | 2025 |
|
|
2023
Q1 | $10.9K | Sell |
3,457
-7,614
| -69% | -$23.9K | ﹤0.01% | 1866 |
|
|
2022
Q4 | $65.3K | Buy |
11,071
+10,076
| +1,013% | +$59.4K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $9K | Buy |
+995
| New | +$9K | ﹤0.01% | 1840 |
|
|
2022
Q1 | – | Sell |
-41,897
| Closed | -$1.35M | – | 2209 |
|
|
2021
Q4 | $1.35M | Sell |
41,897
-16,715
| -29% | -$538K | ﹤0.01% | 1165 |
|
|
2021
Q3 | $2.62M | Buy |
+58,612
| New | +$2.62M | 0.01% | 974 |
|
|
2021
Q2 | – | Sell |
-38,975
| Closed | -$1.44M | – | 2217 |
|
|
2021
Q1 | $1.44M | Buy |
+38,975
| New | +$1.44M | ﹤0.01% | 1236 |
|